VUZE Medical was incorporated in 2017 in Israel and is financed privately. Milestones so far include high accuracy and speed on an anatomical model (2018) and in cadaver surgeries (2019-2020), a first US Patent (2020), interoperability with X-Ray C-Arms from multiple vendors (2021), first European and Asian patents (2021), an FDA 510(k) submission (2021), successful first-in-human surgeries (late 2021) and FDA 510 (k) clearance (early 2022).
Developing the world’s first software-only surgical guidance for skeletal surgery, with a current focus on spine. Addressing the “Neglected Majority” of spine surgeries: Manual, guided only by X-Ray, performed on a short spinal segment, and increasingly in an outpatient/ambulatory setting. VUZE fuses standard in-surgery X-Rays (2D) with a standard pre-surgery CT scan (3D) in real time to provide surgeons with the online images they need most and currently do not have https://www.vuzemedical.com